Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
89.43
Dollar change
-0.33
Percentage change
-0.37
%
Index- P/E42.24 EPS (ttm)2.12 Insider Own1.62% Shs Outstand493.20M Perf Week0.68%
Market Cap44.12B Forward P/E25.45 EPS next Y3.51 Insider Trans0.00% Shs Float485.31M Perf Month13.43%
Income1.05B PEG2.66 EPS next Q0.73 Inst Own54.68% Short Float0.69% Perf Quarter11.05%
Sales9.56B P/S4.61 EPS this Y11.79% Inst Trans- Short Ratio3.58 Perf Half Y22.78%
Book/sh42.13 P/B2.12 EPS next Y14.72% ROA3.56% Short Interest3.33M Perf Year14.68%
Cash/sh2.31 P/C38.66 EPS next 5Y15.91% ROE5.15% 52W Range69.44 - 91.08 Perf YTD14.48%
Dividend Est.0.28 (0.32%) P/FCF45.11 EPS past 5Y- ROI4.08% 52W High-1.81% Beta0.97
Dividend TTM0.26 (0.30%) Quick Ratio1.49 Sales past 5Y6.18% Gross Margin55.74% 52W Low28.79% ATR (14)1.56
Dividend Ex-DateMay 10, 2024 Current Ratio2.51 EPS Y/Y TTM206.49% Oper. Margin14.85% RSI (14)66.03 Volatility1.19% 1.35%
Employees25315 Debt/Eq0.24 Sales Y/Y TTM7.68% Profit Margin10.96% Recom1.77 Target Price95.56
Option/ShortYes / Yes LT Debt/Eq0.23 EPS Q/Q42.20% Payout13.52% Rel Volume0.68 Prev Close89.76
Sales Surprise-0.78% EPS Surprise7.44% Sales Q/Q4.55% EarningsMay 13 AMC Avg Volume930.63K Price89.43
SMA206.96% SMA507.95% SMA20013.36% Trades Volume631,211 Change-0.37%
Date Action Analyst Rating Change Price Target Change
May-15-24Upgrade Oppenheimer Perform → Outperform $103
Apr-10-24Initiated Goldman Buy $100
Mar-14-24Initiated RBC Capital Mkts Sector Perform
Feb-06-24Resumed KeyBanc Capital Markets Overweight $87
Jan-23-24Initiated Bernstein Outperform $94.40
Dec-18-23Downgrade Redburn Atlantic Neutral → Sell
Dec-12-23Initiated Stifel Buy $85
Dec-04-23Downgrade Morgan Stanley Equal-Weight → Underweight $85 → $65
Aug-17-23Upgrade JP Morgan Neutral → Overweight $79.80 → $89.30
May-30-23Resumed Morgan Stanley Equal-Weight $85
May-24-24 09:53AM
May-23-24 09:40AM
08:40AM
May-20-24 10:53AM
May-15-24 08:18AM
05:03PM Loading…
May-14-24 05:03PM
04:31PM
12:55PM
May-13-24 04:30PM
May-10-24 08:52AM
May-08-24 04:30PM
Apr-18-24 08:49AM
Apr-07-24 05:59PM
Apr-03-24 09:51AM
Mar-29-24 05:02PM
11:37AM Loading…
Mar-14-24 11:37AM
Mar-13-24 08:34AM
Mar-12-24 04:30AM
Mar-08-24 02:53PM
07:31AM
Mar-06-24 09:55AM
Feb-29-24 04:19AM
Feb-28-24 03:39PM
05:53AM
Feb-27-24 07:00PM
04:30PM
10:40AM
06:46AM
Feb-22-24 09:15AM
Feb-05-24 01:16PM
09:02AM Loading…
Feb-01-24 09:02AM
Jan-10-24 05:22AM
Jan-09-24 04:30PM
Jan-05-24 08:00AM
Jan-04-24 09:44AM
Dec-27-23 09:01AM
Nov-15-23 12:31PM
Nov-14-23 04:30PM
Nov-08-23 09:03AM
Oct-30-23 09:41AM
09:01AM
Oct-11-23 10:04AM
09:40AM
Oct-10-23 08:01AM
Oct-02-23 09:35AM
Sep-09-23 01:01AM
Sep-06-23 04:30PM
Aug-17-23 09:39AM
Aug-16-23 02:08PM
Aug-15-23 04:30PM
Jul-17-23 07:43AM
Jul-11-23 06:42PM
May-22-23 04:51PM
01:01AM
May-19-23 11:16AM
May-16-23 06:40AM
May-15-23 08:08AM
May-10-23 12:34PM
May-09-23 04:43PM
04:34PM
May-06-23 03:00PM
May-05-23 04:30PM
May-01-23 10:44AM
Apr-14-23 07:08AM
06:53AM
Mar-29-23 05:59PM
04:58PM
Mar-23-23 09:05AM
Mar-20-23 08:55AM
Mar-12-23 11:44PM
Mar-03-23 10:19AM
Mar-01-23 09:03AM
Feb-28-23 07:08PM
Feb-27-23 04:30PM
Feb-12-23 09:05PM
Feb-06-23 07:38AM
Feb-02-23 12:27PM
Jan-23-23 12:58PM
12:43PM
Jan-13-23 06:54PM
Jan-05-23 01:05AM
Dec-28-22 10:05AM
Dec-16-22 04:04AM
Dec-02-22 12:14AM
Nov-29-22 08:30PM
Nov-24-22 02:26PM
Nov-23-22 10:24AM
08:24AM
Nov-22-22 01:01AM
Nov-16-22 11:04PM
11:01AM
Nov-15-22 04:30PM
Nov-02-22 09:27AM
Oct-31-22 05:45PM
Oct-26-22 01:46PM
Oct-05-22 09:25AM
Sep-29-22 09:02AM
Sep-13-22 12:01PM
Aug-29-22 12:08PM
Aug-26-22 09:03AM
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Geneva, Switzerland.